---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-114757"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T21:06:46.667851+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Quoin to effect 1-for-60,000 reverse stock split on Nov 8; ADS ratio changes to 1:1

## Summary
- Reverse split of ordinary shares at 1-for-60,000 ratio effective November 8, 2023.
- Authorized ordinary share capital reduced from 6 trillion to 100 million shares.
- Each ADS will represent one ordinary share post-split (previously 60,000 ordinary shares).
- Shareholders approved three-year frequency for say-on-pay; board adopted that cycle.

## SEC filing metadata
- accession: 0001104659-23-114757
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465923114757/0001104659-23-114757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465923114757/tm2330024d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-114757
- JSON: https://secwatch.observer/filing/0001104659-23-114757.json
- Plain text: https://secwatch.observer/filing/0001104659-23-114757.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.